Acceptance and importance of clinical pharmacists' LIMM-based recommendations.
Int J Clin Pharm
; 34(2): 272-6, 2012 Apr.
Article
em En
| MEDLINE
| ID: mdl-22252773
OBJECTIVE: The objective of this study was to evaluate the quality of the clinical pharmacy service in a Swedish hospital according to the Lund Integrated Medicine Management (LIMM) model, in terms of the acceptance and clinical significance of the recommendations made by clinical pharmacists. METHOD: The clinical significance of the recommendations made by clinical pharmacists was assessed for a random sample of inpatients receiving the clinical pharmacy service in 2007. Two independent physicians retrospectively ranked the recommendations emerging from errors in the patients' current medication list and actual drug-related problems according to Hatoum, with rankings ranging between 1 (adverse significance) and 6 (extremely significant). RESULTS: The random sample comprised 132 patients (out of 800 receiving the service). The clinical significance of 197 recommendations was assessed. The physicians accepted and implemented 178 (90%) of the clinical pharmacists' recommendations. Most of these recommendations, 170 (83%), were ranked 3 (somewhat significant) or higher. CONCLUSION: This study provides further evidence of the quality of the LIMM model and confirms that the inclusion of clinical pharmacists in a multi-professional team can improve drug therapy for inpatients. The very high level of acceptance by the physicians of the pharmacists' recommendations further demonstrates the effectiveness of the process.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Farmacêuticos
/
Serviço de Farmácia Hospitalar
/
Médicos
/
Qualidade da Assistência à Saúde
/
Atitude do Pessoal de Saúde
/
Conhecimentos, Atitudes e Prática em Saúde
/
Modelos Organizacionais
/
Conduta do Tratamento Medicamentoso
/
Erros de Medicação
Tipo de estudo:
Etiology_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
País/Região como assunto:
Europa
Idioma:
En
Revista:
Int J Clin Pharm
Ano de publicação:
2012
Tipo de documento:
Article
País de afiliação:
Suécia